Saturday, November 23, 2024
HomeTagsEugene Schneider

Eugene Schneider

Ionis Provides Update on Development Program Evaluating PCSK9 Antisense Medicine

Ionis Pharmaceuticals, Inc. announced that topline results from the Phase 2b SOLANO study in patients with hypercholesterolemia demonstrated that 60mg of ION449 (AZD8233) administered...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics